Medical research is constantly evolving, research and studies have just started and only small part of the complex impact on the human body by phytobinoids is known so far. The phytocomplex preparations extracted from the plant contain hundreds of substances that are suitable for human administration in the medical field.
The main project was born in 2016 and is focused on CBG (cannabigerol), one of many other non-psychoactive cannabinoids, the precursor of all other cannabinoids. Other projects aim to create varieties with a marked presence of certain terpenes, volatile substances responsible for odours, which are already recognized as medicine themselves (aromatherapy). There are dozens and dozens of terpenes present in hemp, some with very interesting properties for medical use especially if combined with specific cannabinoids ratios.
Swiss Cannabinoid is focused on researching new strains, it's a very long job but it's strictly necessary in order to improve the offer on the market.